Article Details
Retrieved on: 2024-11-02 13:49:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
He underwent treatment with panitumumab, a humanized monoclonal antibody targeting EGFR. Three weeks after initiating therapy, the patient developed a ...
Article found on: www.cureus.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here